Sunrest Lifescience share news and announcements

NSE: SUNRESTPharmaceuticals & Biotechnology

₹33.50₹1.50 (4.29%)

Share price at the NSE close on 23 Oct 2026. Previous close ₹35.00.

52-week range of traded prices to 23 Oct 2026

₹29.55Low, 21 Jan 2026₹54.00High, 25 Nov 2025

Market cap: ₹29 Cr
P/E: 7.0
P/B: Shares changed
Dividend yield: Nonein the last 12 months
ROE: 22.4%
Debt to equity: 0.59
Volume, NSE: 4,80066.7% delivered

Sunrest Lifescience board meetings

47 filed, newest first.

Sep 2026
- 11 Sep · Board meeting
  Outcome of Board Meeting held on September 11, 2026 in relation to Dissolving the Right Issue due to non receipt of minimum subscription and other other matters (opens in a new tab)
Aug 2026
- 12 Aug · Board meeting
  Outcome of Board Meeting held on 12th August, 2026 (opens in a new tab)
- 6 Aug · Board meeting
  To consider other business matters (opens in a new tab)
- 3 Aug · Board meeting
  Board meeting to be held on August 03, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on August 04, 2026, To consider Fund Raising and other business matters (opens in a new tab)
Jul 2026
- 30 Jul · Board meeting
  Board meeting to be held on July 30, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on August 03, 2026, To consider Fund Raising and other business matters (opens in a new tab)
- 24 Jul · Board meeting
  Board meeting to be held on July 24, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on July 30, 2026, To consider Fund Raising and other business matters (opens in a new tab)
- 17 Jul · Board meeting
  Board meeting to be held on July 17, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on July 24, 2026, To consider Fund Raising and other business matters (opens in a new tab)
- 11 Jul · Board meeting
  Board meeting to be held on July 10, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on July 17, 2026, To consider Fund Raising and other business matters (opens in a new tab)
- 2 Jul · Board meeting
  Board meeting to be held on July 02, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on July 10, 2026, To consider Fund Raising and other business matters (opens in a new tab)
Jun 2026
- 26 Jun · Board meeting
  To consider Fund Raising and other business matters (opens in a new tab)
- 26 Jun · Board meeting
  Outcome of Board Meeting held on Jun 26, 2026. (opens in a new tab)
- 22 Jun · Board meeting
  To consider Fund Raising and other business matters (opens in a new tab)
May 2026
- 25 May · Board meeting
  To consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the Half year and year ended 31st March, 2026 along with the Audit Report issued by the Statutory Auditor. (opens in a new tab)
- 14 May · Board meeting
  Outcome of Board Meeting held on May 14, 2026 for Reconstitution of the Committee (opens in a new tab)
Apr 2026
- 30 Apr · Board meeting
  Outcome of Board Meeting held on April 30, 2026 for Dissolving the Right Issue and other matters. (opens in a new tab)
Mar 2026
- 16 Mar · Board meeting
  Board meeting to be held on March 16, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on March 17, 2026, To consider Fund Raising and other business matters (opens in a new tab)
- 10 Mar · Board meeting
  Board meeting to be held on March 10, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on March 16, 2026, To consider Fund Raising and other business matters (opens in a new tab)
- 6 Mar · Board meeting
  Board meeting to be held on March 06, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on March 10, 2026, To consider Fund Raising and other business matters (opens in a new tab)
- 2 Mar · Board meeting
  Board meeting to be held on March 02, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on March 06, 2026, To consider Fund Raising and other business matter (opens in a new tab)
Feb 2026
- 25 Feb · Board meeting
  Board meeting to be held on February 25, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on March 02, 2026, To consider Fund Raising and other business matters (opens in a new tab)
- 19 Feb · Board meeting
  Board meeting to be held on February 19, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on February 25, 2026, To consider Fund Raising and other business matters (opens in a new tab)
- 13 Feb · Board meeting
  Intimation of Board Meeting to be held on 19th February, 2026 to consider Fund Raising through Right issue and other business matters (opens in a new tab)
- 13 Feb · Board meeting
  Outcome of Board Meeting held on February 13, 2026 for the purpose of raising of funds through right issue and other matters (opens in a new tab)
- 10 Feb · Board meeting
  To consider Fund Raising a Proposal of fund raising by way of issue of equity shares through right issue and matters relating to it and other business matters (opens in a new tab)
Jan 2026
- 16 Jan · Board meeting
  Outcome of Board Meeting held on January 16, 2026. (opens in a new tab)
- 16 Jan · Board meeting
  Board meeting held on January 16, 2026. (opens in a new tab)
Nov 2025
- 13 Nov · Board meeting
  Board meeting held on November 13, 2025. (opens in a new tab)
- 5 Nov · Board meeting
  To consider and approve the financial results for the period ended September 30, 2025 (opens in a new tab)
Sep 2025
- 3 Sep · Board meeting
  Board meeting held on September 03, 2025. (opens in a new tab)
Aug 2025
- 1 Aug · Board meeting
  Board meeting held on August 01, 2025. (opens in a new tab)
May 2025
- 30 May · Board meeting
  Board meeting held on May 30, 2025. (opens in a new tab)
- 27 May · Board meeting
  Board meeting to be held on May 27, 2025 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 30, 2025, To consider and approve the financial results for the period ended March 31, 2025 (opens in a new tab)
- 13 May · Board meeting
  To consider and approve the financial results for the period ended March 31, 2025 (opens in a new tab)
  Not held on this date
Mar 2025
- 26 Mar · Board meeting
  Board meeting held on March 26, 2025. (opens in a new tab)
- 24 Mar · Board meeting
  Appointment of Company Secretary and Compliance officer of the Company (opens in a new tab)
- 24 Mar · Board meeting
  Board meeting held on March 24, 2025. (opens in a new tab)
Dec 2024
- 24 Dec · Board meeting
  To take a note on the Resignation of Ms. Nishi Shah as the Company Secretary and Compliance officer of the Company from close of business hour on December 17th, 2024. (opens in a new tab)
Nov 2024
- 14 Nov · Board meeting
  Board meeting held on November 14, 2024. (opens in a new tab)
- 6 Nov · Board meeting
  To consider and approve the financial results for the period ended September 30, 2024 (opens in a new tab)
Jun 2024
- 17 Jun · Board meeting
  Appointment of Secretarial Auditor and Internal Auditor for the FY 2024 - 25 (opens in a new tab)
May 2024
- 27 May · Board meeting
  Board meeting held on May 27, 2024 Where the Board of Directors have Considered and approved Standalone Audited Financial Results of the company for the half year and year ended 31st March, 2024. (opens in a new tab)
- 17 May · Board meeting
  To consider and approve the financial results for the period ended March 31, 2024 (opens in a new tab)
Mar 2024
- 21 Mar · Board meeting
  Consent of the Board of directors of the Company is hereby accorded to dispose of 11,000 equity shares of Rs. 10 each of the company TRILEND PHARMACEUTICALS PRIVATE LIMITED (CIN: U24100GJ2019PTC106321) held as an Investment. (opens in a new tab)
Feb 2024
- 7 Feb · Board meeting
  To appoint Asnani Stock Broker Private Limited (Member of BSE, NSE, CDSL, MCX, NCDEX) having SEBI Registration No INZ000190431 as an Additional Market Maker of the Company (opens in a new tab)
Jan 2024
- 23 Jan · Board meeting
  1. Considered and approved Standalone Unaudited Financial Results along with Limited Review Report of the company for the half year ended 30th September, 2023.2. Mr. Jinang Dineshkumar Shah, a Practicing Company Secretary, Proprietor of M/S Jinang Shah & Associates is hereby appointed for conducting a secretarial audit of the company for the Financial year 2023-24 w.e.f 23.01.2024.3. Mr. Birjesh H. Vithalani, Partner at VRCA & Associates is hereby appointed as an Internal Auditor of the Company for the Financial Year 2023 24 w.e.f 23.01.2024. (opens in a new tab)
- 23 Jan · Board meeting
  1. Considered and approved Standalone Unaudited Financial Results along with Limited Review Report of the company for the half year ended 30th September, 2023.2. Mr. Jinang Dineshkumar Shah, a Practicing Company Secretary, Proprietor of M/S Jinang Shah & Associates is hereby appointed for conducting a secretarial audit of the company for the Financial year 2023-24 w.e.f 23.01.2024.3. Mr. Birjesh H. Vithalani, Partner at VRCA & Associates is hereby appointed as an Internal Auditor of the Company for the Financial Year 2023 24 w.e.f 23.01.2024. (opens in a new tab)
- 17 Jan · Board meeting
  To consider and approve the financial results for the period ended September 30, 2023, Appointment of Secretarial Auditor and Appointment of Internal Auditor of the Company. (opens in a new tab)

Sunrest Lifescience board meetings

Sep 2026

Aug 2026

Jul 2026

Jun 2026

May 2026

Apr 2026

Mar 2026

Feb 2026

Jan 2026

Nov 2025

Sep 2025

Aug 2025

May 2025

Mar 2025

Dec 2024

Nov 2024

Jun 2024

May 2024

Mar 2024

Feb 2024

Jan 2024